Walleye Capital’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-36,469
| Closed | -$478 | – | 2910 |
|
|
2024
Q3 | $478 | Hold |
36,469
| – | – | ﹤0.01% | 2416 |
|
|
2024
Q2 | $1.54K | Hold |
36,469
| – | – | ﹤0.01% | 2554 |
|
|
2024
Q1 | $1.9K | Hold |
36,469
| – | – | ﹤0.01% | 2525 |
|
|
2023
Q4 | $1.82K | Hold |
36,469
| – | – | ﹤0.01% | 2023 |
|
|
2023
Q3 | $8.02K | Hold |
36,469
| – | – | ﹤0.01% | 1950 |
|
|
2023
Q2 | $4.74K | Hold |
36,469
| – | – | ﹤0.01% | 1840 |
|
|
2023
Q1 | $1.5K | Hold |
36,469
| – | – | ﹤0.01% | 2009 |
|
|
2022
Q4 | $1.82K | Hold |
36,469
| – | – | ﹤0.01% | 1968 |
|
|
2022
Q3 | $2K | Buy |
36,469
+4,940
| +16% | +$271 | ﹤0.01% | 2120 |
|
|
2022
Q2 | $3K | Hold |
31,529
| – | – | ﹤0.01% | 2158 |
|
|
2022
Q1 | $11K | Hold |
31,529
| – | – | ﹤0.01% | 2011 |
|
|
2021
Q4 | $16K | Buy |
+31,529
| New | +$16K | ﹤0.01% | 1914 |
|